Limited Submissions Calendar

A number of external funding programs limit the number of applications the University of Arizona may submit.  If you would like to be considered for a limited solicitation opportunity, please submit a pre-proposal to your college Dean prior to the internal deadlines listed below. Please review eligibility requirements carefully. If you identify a program that we have not listed that limits submissions, or if you have questions about any of the limited solicitations listed below, please contact Research Development Services.

Please note that proposals to private foundations may require clearance through the University of Arizona Foundation.

Program Title Sponsorsort descending Funding Type RDI Deadline External Deadline Notes
2021 May Medical Scientist Training Program (T32) National Institutes of Health (NIH) Grants 03/24/2021

05/25/2021

T. Vanderah

2021 Postbaccalaureate Research Education Program (PREP) (R25 - Independent Clinical Trial Not Allowed) National Institutes of Health (NIH) Grants 11/18/2020

01/27/2021

No applicants.

2021 NIH Director's Early Independence Awards (DP5 Clinical Trial Optional) National Institutes of Health (NIH) 07/14/2021

09/03/2021

No applicants // Limit: 2 // Tickets Available: 2 

 

The NIH Director's Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

T. Sawyer
E. Blackwood

NIH PAR-23-306: 2024 Biomedical Research Facilities (C06 Clinical Trial Not Allowed) National Institutes of Health (NIH) Equipment or Infrastructure 10/11/2023

01/25/2024

Institutionally Coordinated // Limit: 1 // M. Dake ( University of Arizona Health Sciences)

 

Moreover, institutions with C06 awards funded under the Biomedical Research Facility Program (NOFOs PAR-21-139PAR-22-088 or PAR-23-045) are not eligible to apply to this NOFO, provided the awards are active on the receipt date for this NOFO. Thus, only one C06 Biomedical Research Facility active award per institution would be allowed at any given time.

This Notice of Funding Opportunity (NOFO) invites applications from eligible academic and research institutions to apply for funding to modernize existing or construct new biomedical research facilities. Applications will be accepted from public and private nonprofit institutions of higher education as well as from non-profit research organizations. Applications from both research-intensive institutions and Institutions of Emerging Excellence (IEE) in biomedical research, both highly resourced and low-resourced institutions, from all geographic regions in the nation are strongly encouraged.

NIH recognizes the importance of all institutions of higher learning in contributing to the nation’s research capacity. The goal of this NOFO is to modernize biomedical research infrastructure to strengthen biomedical research programs. Each project is expected to provide long-term improvements to the institutional research infrastructure. Intended projects are the construction or modernization of core facilities and the development of other shared research infrastructure serving an institution-wide research community with broad impact on biomedical research.

NIH PAR-21-338: 2024 Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) National Institutes of Health (NIH) Research and Training 10/11/2023

01/12/2024

No applicants // Limit: 1 // Tickets Available: 1 

 

The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Institutional Research Training Grants for the Clinical and Translational Science Awards (CTSA) Program (T32) to eligible institutions to enhance postdoctoral research training of individuals with doctoral degrees (these include, but are not limited to, the following: D.M.D., DC, DO, DVM., OD, DPM, ScD, EngD, DrPH, DNSc, DPT, PharmD, ND [Doctor of Naturopathy], DSW, PsyD, as well as a doctoral degree in nursing research) and help ensure a heterogenous pool of clinical and translational scientists trainees are equipped with the knowledge, skills and abilities to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications that improve health.

NCATS will not accept applications proposing combined predoctoral and postdoctoral training under this FOA. Applications proposing predoctoral research training should apply to the Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (PAR-21-337).

The proposed institutional research training program may complement other ongoing research training and career development programs at the applicant institution, but must be clearly distinct from related programs currently receiving Federal support.

 

This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial on which the PI is a mentor or co-mentor.

NCATS solicits the submission of one set of companion applications. With this solicitation for the T32 application, a separate, companion FOA solicits applications for a required UM1 (PAR-21-293: Clinical and Translational Science Award). The UM1 and initial T32 applications must be submitted concurrently; a T32 application without the required companion UM1 application will not be reviewed. The T32 application will only be awarded if the UM1 application is awarded. Resubmission of a T32 without the required UM1 will be allowed only if the UM1 application is awarded.

The sponsoring institution must assure support for the proposed program. Appropriate institutional commitment to the program includes the provision of adequate staff, facilities, and educational resources that can contribute to the planned program.

 

NIH RFA-ES-23-001 2023:Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) National Institutes of Health (NIH) Research and Training 05/30/2023

10/02/2023

X. Ding (Pharmacy) - Competitive resubmission. 

 

UA may submit one proposal.

The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes research translation), data management and analysis, community engagement, research experience and training coordination, and research support functions. The scope of the SRP Centers is taken directly from the Superfund Amendments and Reauthorization Act of 1986, and includes: (1) advanced techniques for the detection, assessment, and evaluation of the effect on human health of hazardous substances; (2) methods to assess the risks to human health presented by hazardous substances; (3) methods and technologies to detect hazardous substances in the environment; and (4) basic biological, chemical, and physical methods to reduce the amount and toxicity of hazardous substances.

2021 January Data Science Research: Personal Health Libraries for Consumers and Patients (R01 Clinical Trial Optional) National Institutes of Health (NIH) Grants 11/18/2020

01/19/2021

No applicants.

Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional) National Institutes of Health (NIH) Grants 10/07/2020

12/01/2020

No applicants.

2021 March deadline The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Independent Clinical Trial Not Allowed) National Institutes of Health (NIH) Grants 01/06/2021

03/02/2021

No applicants.

NIH PAR-23-114: 2023 Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed) National Institutes of Health (NIH) Training 07/17/2023

01/17/2024

Limit: 1  // PI: M. Romero-Ortega (Biomedical Engineering)

 

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

To accomplish the stated over-arching goal, this FOA will support educational activities with a primary focus on:

  • Courses for Skills Development
  • Research Experiences

The ESTEEMED program is designed to foster the development of undergraduate freshmen and sophomores from diverse backgrounds to pursue further studies and careers in bioengineering or STEM fields relevant to NIBIB’s scientific mission. Applications are encouraged to propose integrated educational activities that include 3 elements: a summer bridge program for incoming freshmen, and in the freshman and sophomore years, academic year activities and summer research experiences. The ESTEEMED program is intended to expose students to bioengineering research early in their college careers while also providing students didactic, mentoring and career development opportunities. This will prepare students to join, in their junior and senior years, an honors program that promotes STEM and entrance into a Ph.D. program. The ultimate goal is for the participants to pursue a doctoral degree and a subsequent research career in bioengineering or NIBIB-relevant field.

Components of Participating Organizations:
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

 

NIH-NHLBI RFA-HL-24-004: 2023 Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) National Institutes of Health (NIH) Research and Training 01/03/2023

03/10/2023

S. Parthasarathy ( College of Medicine - of Pulmonary Allergy Critical Care and Sleep Medicine) 
 

The NIH Research Education Program (R25) supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers. 

The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

The National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases, and sleep disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI expects efforts to diversify the workforce to lead to the recruitment of researchers from all groups, improve the quality of the educational and training environment, balance and broaden the perspective in setting research priorities, improve the ability to recruit subjects from diverse backgrounds into clinical research protocols, and improve the Nation's capacity to address and eliminate health disparities.

The overarching goal of this National Heart, Lung, and Blood Institute (NHLBI) R25 program is to support mentoring and research education activities that enhance the diversity of the biomedical, behavioral and clinical research workforce. The major goal of this R25 program is to establish long-term mentoring that will enable junior faculty and transitioning postdoctoral students from diverse backgrounds, including those from groups that are underrepresented in the biomedical sciences (see, e.g., NOT-OD-20-031), to develop a research program and work with their home institution to obtain NIH funding. This FOA specifically invites applications that would support senior faculty, established researchers, and experienced mentors to develop and direct the Summer Institutes for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) in order to mentor promising eligible junior faculty and transitioning postdoctoral students from diverse backgrounds who have specific scientific interests in heart, lung, blood and sleep (HLBS) disorders research.

To accomplish the stated over-arching goal, this FOA will support educational activities with a primary focus on Research Experiences and Mentoring Activities (described below):

  • Research Experiences for participating junior faculty and transitioning postdoctoral students from diverse backgrounds to enhance their research skills, experiences, and knowledge base relative to HLBS scientific areas and cross-cutting methodological approaches. This can include transitioning postdoctoral scientists who have received a formal full-time faculty appointment letter in hand and will have completed their postdoctoral appointment by the time the Summer Institute program to which they are recruited is convened.   
  • Mentoring Activities by senior faculty, established researchers, and experienced mentors that include dedicated efforts to provide technical expertise, career advice, insight, and professional skills development opportunities to participating junior faculty and transitioning postdoctoral students from diverse backgrounds so that they can work with their institutions to compete for NIH grantss successfully.

Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g., T32, T90) but cannot be used to replace or circumvent Ruth L. Kirschstein National Research Service Award (NRSA) programs.

 

 

NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) National Institutes of Health (NIH) Grants 12/16/2020

04/23/21

No applicants.

2020 NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) National Institutes of Health (NIH) Grants 10/14/2020

11/18/2020

No applicants.

NIH 2024 S10 Instrumentation Programs: Shared Instrumentation Grant Program (SIG) & High-End Instrumentation Grant Program (HEI) National Institutes of Health (NIH) Equipment or Infrastructure 11/01/2023

06/03/2024

Contact RDS to apply // Institutionally coordinated

 

ORIP's S10 Instrumentation Grant Programs support purchases of state-of-the-art commercially available instruments to enhance research of NIH-funded investigators. Instruments that are awarded are typically too expensive to be obtained by an individual investigator with a research project grant. Every instrument awarded by an S10 grant is to be used on a shared basis, which makes the programs cost-efficient and beneficial to thousands of investigators in hundreds of institutions nationwide.

To be eligible for an S10 award, an institution must identify three or more principal investigators with active NIH research awards who demonstrate a substantial need for the requested instrument. Matching funds are not required. Types of instruments supported by S10 funding include, but are not limited to, X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-analyzers, and biomedical imagers.

Active RFPs are: 

There is no restriction on the number of applications an institution can submit to the SIG and/or High-End HEI Grant Programs. However, institutional internal coordination is required for concurrent SIG or HEI applications to verify each proposal is requesting different types of equipment.

Solicitation 

Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required) National Institutes of Health (NIH) Grants 10/07/2020

12/01/2020

No applicants.

2021 New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed) National Institutes of Health (NIH) Grants 05/05/2021

07/08/2021

UA may submit 1 application. 

The purpose of the ASPIRE Collaborative Research Program is to facilitate translational and clinical research between NCATS intramural scientists and the extramural community to develop approaches that will enhance the ability to discover and develop new chemistries towards previously undrugged biological targets (i.e., biological targets with no known drugs to modulate their function) across many human diseases and conditions. NCATS intramural scientists have established an integrated NCATS ASPIRE platform consisting of physical and virtual modules for automated synthetic chemistry, artificial intelligence (AI) and machine learning (ML), engineering, informatics, and biological testing. The FOA will support intramural - extramural collaborations to develop additional physical modules that will enhance the platform's capabilities. The anticipated outcome includes identification, design, synthesis, and validation of new chemical entities as starting points for drug development of novel targets, and the expansion of chemical space available for drug screening.Components of Participating Organizations:National Center for Advancing Translational Sciences (NCATS)

No applicants.

2021 (SIG) Shared Instrumentation Grant Program (S10 Clinical Trial Not Allowed) National Institutes of Health (NIH) Grants 03/17/2021

06/01/2021

UA may submit more than one application.

There is no restriction on the number of applications an institution can submit to the SIG and/or High-End Instrumentation (HEI) Programs each year, provided the applications request different types of equipment. To prevent duplication of applications, this opportunity is Institutionally Coordinated. Applications will be accepted that request a single, commercially available instrument or an integrated instrumentation system. The minimum award is $50,000. There is no upper limit on the cost of the instrument, but the maximum award is $600,000. Since the cost of various instruments will vary, it is anticipated that the amount of the award will also vary. S10 awards do not allow indirect costs.

H-H., Chow
C. Miranti
C. Glembotski

NIH RFA-AG-24-013: 2023 NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 - Independent Clinical Trial Not Allowed) National Institutes of Health (NIH) Research and Training 10/18/2023

05/25/2024

Limit: 2* // Tickets Available: 1 // M. H.Witte (Surgery, Neurosurgery, and Pediatrics) 

*No more than two applications are allowed per institution. If two applications are submitted then the 2 awards must be for different target groups.
 

A major goal of the National Plan to address Alzheimer’s Disease (AD) and Alzheimer’s Disease-related Dementias (ADRD)  is to reduce the burden of AD/ADRD by accelerating research toward treatments, improving care and support for people facing these conditions now, and reducing the risk of AD/ADRD by promoting brain health. Despite this, there is a shortage of scientists conducting the wide variety of necessary innovative and interdisciplinary research projects, including basic biomedical, clinical, translational, prevention, and treatment research on AD/ADRD. This Funding Opportunity Announcement (FOA) aims to address goal G-4 of the National Institute on Aging's Strategic Directions for Research (2020-2025): “Attract and train more researchers from diverse scientific and cultural backgrounds." This will include supporting the recruitment of early-stage investigators from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to the NIH AD/ADRD portfolio. This FOA also aims to address the lack of early exposure to high-quality, hands-on research education experiences in the AD/ADRD field, another major barrier to increasing the AD/ADRD capable workforce.

To further expand the AD/ADRD training pipeline for earlier stage students, NIA will support summer research experiences for high school students, undergraduates, or science teachers. The expectation is that such a program would incubate and develop the next generation of  early-stage investigators to pursue research careers representative of in NIA mission critical areas, namely AD/ADRD research. Proposed programs should provide authentic "open-ended", hands-on exposure to AD/ADRD research as it relates to aging as part of a comprehensive program based in sound educational practices designed to stimulate the interest and advance the knowledge base of participants. In addition to hands-on research experiences, programs are expected to include complementary educational enrichment activities that support the participants' scientific development, such as relevant workshops (e.g., scientific writing and presentation skills), journal clubs, technical laboratory coursework, and training in rigor and reproducibility. Program goals and objectives should be grounded in literature and appropriate for the educational level of the audience to be reached, including the content to be conveyed, and the intended outcome(s). Outcomes for high school students may include preparing them for undergraduate admissions and enhancing their interest in pursuing a science decree. Outcomes for college students may include: reinforcing their intent to graduate with a science degree, preparing them for graduate or medical school admissions, and/or preparing them for careers in AD/ADRD research. Support for science teachers will be limited to those programs with a clear plan for how teachers will utilize their summer experience in their teaching during the school year, such as enhancing the STEM curriculum or increasing number of STEM courses taught. 

Focus on High School Students, Undergraduates, or Science Teachers: Science education research has demonstrated that early exposure to scientific research leads to the retention of trainees in science, technology, engineering, and mathematics (STEM). The President’s Council of Advisors on Science and Technology (PCAST) specifically highlights the need for retention of trainees in STEM by involving them in contemporary, hands-on research experiences especially during the first two years of college. Summer research experiences provide important experiential learning to sustain students’ interests in STEM and medicine careers. The short-term summer experience, in contrast to a year-long experience, allows for a focused and concentrated effort on instruction, and intentionally coincides with the time of year when the target populations of this program (i.e., high school students, undergraduate college students, and science teachers) would typically have the opportunity to engage in such a research educational experience. 

For the purpose of this announcement, institutions should explain how this program will be developed in a way that will foster diversity and inclusion at their organization. As indicated below, applicants must include a Recruitment Plan to Enhance Diversity which describes the program’s proposed recruitment efforts and how the proposed plan reflects past experiences in recruiting individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences (see NOT-OD-20-031 for additional information on NIH's Notice of Interest in Diversity). All programs are expected to be inclusive, supportive, and safe, and to provide opportunities for participants to interact with investigators who could contribute to their growth. Applications from a variety of institutions, including those from minority serving institutions (MSIs), are  encouraged.

Applicants should consider how the developed programs can optimize participation and potentially include additional participants from outside the applicant institution, especially those in local and/or affiliated institutions. Applicants must demonstrate how this program will add significant value over existing programs at the applicant institution.

Each institution must have a unique program structure that maximizes resources, departments, and faculty at the applicant institution to address the target population. Applicants are encouraged to propose collaborations with affiliated and/or local institutions, as appropriate. Applicants are also encouraged to partner with existing NIH-funded or other federally-funded resources and programs and leverage training activities from both federal and private-sector partners including, but not limited to, the following:

2020 NINDS Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25) National Institutes of Health (NIH) Grants 11/18/2020

01/25/2021

M. Bhattacharya 

NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) National Institutes of Health (NIH) Grants 03/01/2021

03/01/2021

F. Moreno

NIH RFA-MD-23-011: 2023 NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional) National Institutes of Health (NIH) Center 05/31/2023

08/04/2023

No applicants // Limit: 1 // Tickets Available: 1 

 

UArizona may submit one proposal to this funding program. 

 

The purpose of this RFP is to further advance NIMHD’s mission by supporting Centers of Excellence to enhance research training and education of academic faculty (including post-doctoral fellows, junior faculty, and other early-stage investigators) in the conduct of minority health and health disparities research.
 

NIMHD focuses on the full continuum of causes of health disparities and the interventions to address these causes. Projects must include a focus on one or more of the following NIH-designated populations that experience health disparities in the United States. The Center of Excellence must include the following required components:

  • Overall
  • Administrative Core
  • Investigator Development Core
  • Community Engagement and Dissemination Core
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) National Institutes of Health (NIH) 06/21/2020

08/07/2020

No applicants.

2020 NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed) National Institutes of Health (NIH) Grant 08/05/2020

10/06/2020

No applicants.

PAR-20-153: 2022 NIH (SEPA) Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) National Institutes of Health (NIH) 05/04/2022

07/13/2022

M. Ramirez-Andreotta

Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) National Institutes of Health (NIH) Grants 12/02/2020

02/15/2021

No applicants.

Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now